📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab. (2021)

First Author: Hammond S

Attributed to: Definition of the naturally-processed drug-peptide adducts that can act as functional T-cell antigens funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2021-002521

PubMed Identifier: 34049931

Publication URI: http://europepmc.org/abstract/MED/34049931

Type: Journal Article/Review

Volume: 9

Parent Publication: Journal for immunotherapy of cancer

Issue: 5

ISSN: 2051-1426